SCHEMBL6174848

SCHEMBL6174848

CC(c1ccnc(-c2ccccc2)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
LIPE Q05469 1/20 0.39
ATP1A1 P05023 1/20 0.38
ATP1B1 P05026 1/20 0.38
ATP1A3 P13637 1/20 0.38
ATP1B2 P14415 1/20 0.38
ATP1A2 P50993 1/20 0.38
ATP1B3 P54709 1/20 0.38
FXYD2 P54710 1/20 0.38
ATP1A4 Q13733 1/20 0.38
PDE2A O00408 2/20 0.37
MAT2A P31153 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
FAAH O00519 3/20 0.35
KDM5A P29375 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174756 0.92 MAT2A (0.43) LMNALIPEATP1A1ATP1B1ATP1A3
SCHEMBL6171105 0.92 LMNA (0.39) LMNALIPEATP1A1ATP1B1ATP1A3
SCHEMBL6174788 0.90 LMNA (0.38) LMNALIPEPOLBL3MBTL1SLC5A1
SCHEMBL6174656 0.88 LMNA (0.41) LMNALIPEATP1A1ATP1B1ATP1A3
SCHEMBL6174695 0.85 LMNA (0.39) LMNAPDE2AFAAHMAPKAPK2
SCHEMBL6176756 0.85 LMNA (0.42) LMNALIPEATP1A1ATP1B1ATP1A3
SCHEMBL6173438 0.85 LMNA (0.42) LMNALIPEPDE2APOLBL3MBTL1
SCHEMBL6175578 0.85 LMNA (0.42) LMNALIPEATP1A1ATP1B1ATP1A3
SCHEMBL6177038 0.84 LMNA (0.42) LMNAPDE2APOLBL3MBTL1KDM5A
SCHEMBL6173854 0.84 LMNA (0.45) LMNALIPEATP1A1ATP1B1ATP1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed